1
|
Matsumoto Y, Aikawa H, Narita S, Tsutsumi
M, Yoshida H, Etou H, Sakamoto K, Inoue R, Nii K and Kazekawa K:
Intracranial tuberculoma in non-immunosuppressive state. Neurol Med
Chir (Tokyo). 53:259–262. 2013.PubMed/NCBI View Article : Google Scholar
|
2
|
Perez-Malagon CD, Barrera-Rodriguez R,
Lopez-Gonzalez MA and Alva-Lopez LF: Diagnostic and neurological
overview of brain tuberculomas: A review of literature. Cureus.
13(e20133)2021.PubMed/NCBI View Article : Google Scholar
|
3
|
Verma R and Gupta R: Multiple
ring-enhancing lesions: Diagnostic dilemma between
neurocysticercosis and tuberculoma. BMJ Case Rep.
2014(bcr2013202528)2014.PubMed/NCBI View Article : Google Scholar
|
4
|
Yang M, Zhang JT, Yao Y, Tan QC, Gao T,
Tian CL, Huang X and Yu SY: A clinical study of miliary brain
tuberculomas in China. Jpn J Infect Dis. 69:231–235.
2016.PubMed/NCBI View Article : Google Scholar
|
5
|
Li CR, Li YZ, Li YM and Zheng YS: Dynamic
and contrast enhanced CT imaging of lung carcinoma, pulmonary
tuberculoma, and inflammatory pseudotumor. Eur Rev Med Pharmacol
Sci. 21:1588–1592. 2017.PubMed/NCBI
|
6
|
Sindgikar SP, Narayanaswamy B, Alexander
LM and Kanavu R: Paradoxical immune reconstitution inflammatory
syndrome in neurotuberculosis. BMJ Case Rep.
14(e243739)2021.PubMed/NCBI View Article : Google Scholar
|
7
|
Salman N, Somer A and Yalçın I (eds):
Paediatric Infectious Diseases. Akademi Kitabevi, İstanbul, 2015
(In Türkiye).
|
8
|
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker
S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB,
et al: An official ATS statement: Hepatotoxicity of
antituberculosis therapy. Am J Respir Crit Care Med. 174:935–952.
2006.PubMed/NCBI View Article : Google Scholar
|
9
|
Alsayed SSR and Gunosewoyo H:
Tuberculosis: Pathogenesis, current treatment regimens and new drug
targets. Int J Mol Sci. 24(5202)2023.PubMed/NCBI View Article : Google Scholar
|
10
|
Dhiman RK, Saraswat VA, Rajekar H, Reddy C
and Chawla YK: A guide to the management of tuberculosis in
patients with chronic liver disease. J Clin Exp Hepatol. 2:260–270.
2012.PubMed/NCBI View Article : Google Scholar
|
11
|
Abbara A, Chitty S, Roe JK, Ghani R,
Collin SM, Ritchie A, Kon OM, Dzvova J, Davidson H, Edwards TE, et
al: Drug-induced liver injury from antituberculous treatment: A
retrospective study from a large TB centre in the UK. BMC Infect
Dis. 17(231)2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Turhan A, Tosun Tasar P, Timur Ö,
Karaşahin Ö, Gökgül A and Binici DN: Immune reconstitution
inflammatory syndrome during anti-tuberculous therapy: A case
report. Tepecik Eğit ve Araşt Hast Dergisi. 29:103–106. 2019.(In
Turkish).
|
13
|
Erdoğan FF and Demir S (Ed): (2018).
Neurological Evaluation in Infants and Children. Nörolojik
Değerlendirme, Türk Nöroloji Derneği, Galenos Yayınevi, İstanbul
(In Turkish).
|
14
|
QuantiFERON-TB Gold Plus ELISA
Instructions for Use, March. 2023, QIAGEN GmbH QIAGEN Strasse 1,
40724 Hilden, Almanya.
|
15
|
Menentoğlu B, Şimşek C and Hatipoğlu N:
Administration and interpretation of PPD test. J Pediatr Inf.
15:57–62. 2021.(In Turkish).
|
16
|
Rümke HC: BCG: An almost 100-year-old
vaccine. Ned Tijdschr Geneeskd. 164(D5146)2020.PubMed/NCBI(In Dutch).
|
17
|
Saniç A, Eroğlu C and Kizirgil A:
Identification of mycobacterium species by PCR and RFLP methods.
21. Yüzyılda Tüberküloz Sempozyumu ve II. Tüberküloz Laboratuvar
Tanı Yöntemleri Kursu, Samsun, 2003 (In Turkish).
|
18
|
Gemnani R, Saboo K, Wanjari A, Kumar S and
Acharya S: Tuberculoma masquerading as a sixth cranial nerve palsy
in a young patient: A case report. Cureus.
16(e59469)2024.PubMed/NCBI View Article : Google Scholar
|
19
|
Aslan G and Alkaya D: One hundred of
tuberculosis vaccine: History of bacille calmette-guérin-could BCG
vaccination induce trained immunity? Turk J Immunol. 10:12–21.
2022.
|
20
|
Cherian A, Ajitha KC, Iype T and Divya KP:
Neurotuberculosis: An update. Acta Neurol Belg. 121:11–21.
2021.PubMed/NCBI View Article : Google Scholar
|
21
|
Ech-cherif El kettani N, Jerguigue H,
Karouache A, El quessar A, El hassani MR, Chakir N, Boukhrissi N
and Jiddane M: No 5 Imaging of encephalic tuberculomas. J Radiol.
85(1517)2004.
|
22
|
Dian S, Ganiem AR, Te Brake LH and van
Laarhoven A: Current insights into diagnosing and treating
neurotuberculosis in adults. CNS Drugs. 37:957–972. 2023.PubMed/NCBI View Article : Google Scholar
|
23
|
Gupta RK and Kumar S: Central nervous
system tuberculosis. Neuroimaging Clin N Am. 21:795–814, vii-viii.
2011.PubMed/NCBI View Article : Google Scholar
|
24
|
DeLance AR, Safaee M, Oh MC, Clark AJ,
Kaur G, Sun MZ, Bollen AW, Phillips JJ and Parsa AT: Tuberculoma of
the central nervous system. J Clin Neurosci. 20:1333–1341.
2013.PubMed/NCBI View Article : Google Scholar
|
25
|
Maheswari EU, Bhoopathy RM, Bhanu K and
Anandan H: Clinical spectrum of central nervous system tuberculosis
and the efficacy of revised national tuberculosis control program
in its management. J Neurosci Rural Pract. 10:71–77.
2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Mehta PK, Singh N, Dharra R, Dahiya B,
Sharma S, Sheoran A, Gupta KB, Chaudhary D, Mehta N and Varma-Basil
M: Diagnosis of tuberculosis based on the detection of a cocktail
of mycobacterial antigen 85B, ESAT-6 and cord factor by immuno-PCR.
J Microbiol Methods. 127:24–27. 2016.PubMed/NCBI View Article : Google Scholar
|
27
|
Singh N, Sreenivas V, Gupta KB, Chaudhary
A, Mittal A, Varma-Basil M, Prasad R, Gakhar SK, Khuller GK and
Mehta PK: Diagnosis of pulmonary and extrapulmonary tuberculosis
based on detection of mycobacterial antigen 85B by immuno-PCR.
Diagn Microbiol Infect Dis. 83:359–364. 2015.PubMed/NCBI View Article : Google Scholar
|
28
|
Mehta PK, Raj A, Singh NP and Khuller GK:
Detection of potential microbial antigens by immuno-PCR
(PCR-amplified immunoassay). J Med Microbiol. 63(Pt 5):627–641.
2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Mehta PK, Dahiya B, Sharma S, Singh N,
Dharra R, Thakur Z, Mehta N, Gupta KB, Gupta MC and Chaudhary D:
Immuno-PCR, a new technique for the serodiagnosis of tuberculosis.
J Microbiol Methods. 139:218–229. 2017.PubMed/NCBI View Article : Google Scholar
|
30
|
Ahlawat S, Dabla S, Kumar V, Singh M, Bala
K and Mehta PK: Role of immuno-polymerase chain reaction (I-PCR) in
resolving diagnostic dilemma between tuberculoma and
neurocysticercosis: A case report. Am J Case Rep. 19:599–603.
2018.PubMed/NCBI View Article : Google Scholar
|
31
|
Yurdakul A, Çalışır H, Taci N, Çelik N and
Öğretensoy M: Hepatotoxicity occured during anti-tuberculosis
treatment. Toraks Dergisi. 4:16–20. 2003.(In Turkish).
|
32
|
Kılınc F, Çay Ü, Çetin FT, Tapac N, Ozgur
Gundeslioglu O and Alabaz D: Intracranial tuberculoma developing
during the treatment of a case with tuberculous meningitis caused
by the zoonotic mycobacterium caprae. Klin Padiatr: Feb 6, 2024
(Epub ahead of print).
|
33
|
Bulterys MA, Wagner B, Redard-Jacot M,
Suresh A, Pollock NR, Moreau E, Denkinger CM, Drain PK and Broger
T: Point-of-care urine LAM tests for tuberculosis diagnosis: A
status update. J Clin Med. 9(111)2019.PubMed/NCBI View Article : Google Scholar
|
34
|
Tibúrcio R, Barreto-Duarte B, Naredren G,
Queiroz ATL, Anbalagan S, Nayak K, Ravichandran N, Subramani R,
Antonelli LRV, Satagopan K, et al: Dynamics of T-lymphocyte
activation related to paradoxical tuberculosis-associated immune
reconstitution inflammatory syndrome in persons with advanced HIV.
Front Immunol. 12(757843)2021.PubMed/NCBI View Article : Google Scholar
|
35
|
Marais S, Van Toorn R, Chow FC, Manesh A,
Siddiqi OK, Figaji A, Schoeman JF and Meintjes G: Tuberculous
Meningitis International Research Consortium. Management of
intracranial tuberculous mass lesions: how long should we treat
for? Wellcome Open Res. 4(158)2019.PubMed/NCBI View Article : Google Scholar
|
36
|
Li H, Liu W and You C: Central nervous
system tuberculoma. J Clin Neurosci. 19:691–695. 2012.PubMed/NCBI View Article : Google Scholar
|
37
|
Sadashiva N, Tiwari S, Shukla D, Bhat D,
Saini J, Somanna S and Devi BI: Isolated brainstem tuberculomas.
Acta Neurochir (Wien). 159:889–897. 2017.PubMed/NCBI View Article : Google Scholar
|